Data-Driven Healthcare

A hotspot for medical innovation and expertise, the West Midlands is at the centre of that all-important industry: healthcare.

The West Midlands is a leading UK centre of data-driven healthcare expertise and innovation. Employing over 17,000, the region’s multidisciplinary, urban-centred healthcare ecosystem offers businesses a stand-out speed-to-market opportunity. From early concept to clinical testing and manufacturing, the West Midlands uniquely supports every step of the development cycle, from ‘bench to bedside’. Spearheading the region’s data-driven healthcare proposition are three distinct pillars of opportunity: digital, diagnostics and devices.

Through unrivalled access to electronic clinical and genomic data of scale from a 5.5million-strong, non-transient patient population, the opportunities to test and implement new and impactful healthcare interventions in the West Midlands are endless. This is underscored by one of the most advanced electronic patient record systems in the UK, aggregated by University Hospitals Birmingham (UHB).

Of all the West Midlands’ healthcare specialisms, med-tech presents the greatest opportunity, accounting for 61% of the region’s healthcare sector and 8% of the UK’s overall turnover in the field. The region has successfully translated its skills base - as the manufacturing heartland of the UK - into a leading proving ground for the prototyping, testing and manufacture of medical devices.

Don't forget...

  • There are eight hospitals and 35+ regional centres of clinical research excellence in the West Midlands
  • Over 17,000 people are employed in data-driven healthcare here
  • Five leading universities see over 11,000 medical sciences students graduate here every year
  • The Queen Elizabeth Hospital in Birmingham has the largest single critical care unit in Europe
  • Our 5.5million population creates incredible opportunity to test, analyse and improve healthcare technologies

Did you know?

  • MedTech accounts for 61% of the West Midlands’ life sciences sector